GW-405833 (L-768242) is a drug that acts as a potent and selective partial agonist for the cannabinoid receptor subtype CB2 with an EC50 of 0.65nM and selectivity of around 1200x for CB2 over CB1 receptors. Animal studies have shown it to possess antiinflammatory and anti-hyperalgesic effects at low doses followed by ataxia and analgesic effects when the dose is increased.
This page contains content from the copyrighted Wikipedia article "GW-405833"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
